MedPath

Efficacy of Urinary Follicle-Stimulating Hormone (FSH) Among Poor Responders

Not Applicable
Conditions
Infertility
Interventions
Registration Number
NCT00677573
Lead Sponsor
German Hospital, Istanbul
Brief Summary

We proposed to compare outcomes in women with DOR undergoing ART with rec-FSH + u-HMH with those with u-FSH only in GnRH antagonist protocols.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • At least one trial with adequate ovarian stimulation resulted by 4 or less oocytes retrieval.
Exclusion Criteria
  • High responder patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
UrFSHFostimon-
Primary Outcome Measures
NameTimeMethod
pregnancy rate per embryo transfer6 months
Secondary Outcome Measures
NameTimeMethod
number of oocytes retrievedper patient

Trial Locations

Locations (1)

Alman Hastanesi

🇹🇷

İstanbul, Turkey

Alman Hastanesi
🇹🇷İstanbul, Turkey
Haluk Toygarlı, M.D.
Contact
90-21-2293-2150
ulun ulug, M.D.
Principal Investigator
mustafa bahceci, M.D.
Sub Investigator
enver kurt, M.D.
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.